News
B vitamins play a key role in managing homocysteine and supporting heart health. Based on this study, Vitamin B could be a ...
Topline data were announced from a phase 3 trial that evaluated baxdrostat in patients with uncontrolled or treatment resistant hypertension.
AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary ...
3d
Zacks Investment Research on MSNAstraZeneca Meets All Key Goals in Phase III Hypertension StudyAstraZeneca AZN reported positive top-line results from a late-stage study evaluating the safety, tolerability and efficacy ...
David’s blood pressure was dangerously high until he received specialized care and renal denervation at BIDMC’s Complex Hypertension Clinic. Read his story.
The scope of resistant hypertension has not been quantified, but clinical trials suggest it may affect up to 30 percent of people with high blood pressure.
In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...
Struggling to control high BP? Learn about resistant hypertension, its causes, and expert-approved ways to manage it. Get ...
“Baxdrostat BaxHTN Phase III trials on patients with uncontrolled or treatment-resistant hypertension demonstrated a ...
In addition to taking medication, paying attention to these habits can help maintain healthy blood pressure levels..resistant ...
AstraZeneca's Phase 3 trial showed baxdrostat lowered systolic blood pressure in treatment-resistant hypertension with a ...
Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results